Global Cancer Immunotherapy Drug Discovery Outsourcing

Table of Contents

1 Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

• 1.1 Product Overview and Scope of Cancer Immunotherapy Drug Discovery Outsourcing
• 1.2 Classification of Cancer Immunotherapy Drug Discovery Outsourcing by Types
  • 1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Types in 2018
  • 1.2.3 Monoclonal Antibodies
  • 1.2.4 Immunomodulators
  • 1.2.5 Oncolytic Viral Therapies and Cancer Vaccines
  • 1.2.6 Other
• 1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Application
  • 1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Lung
  • 1.3.3 Breast
  • 1.3.4 Colorectal
  • 1.3.5 Melanoma
  • 1.3.6 Prostate
  • 1.3.7 Head and Neck
  • 1.3.8 Ovarian
  • 1.3.9 Pancreatic
• 1.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Regions
  • 1.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapy Drug Discovery Outsourcing Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cancer Immunotherapy Drug Discovery Outsourcing (2014-2024)

2 Manufacturers Profiles

• 2.1 Aquila BioMedical
  • 2.1.1 Business Overview
  • 2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 BPS Bioscience, Inc.
  • 2.2.1 Business Overview
  • 2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Celentyx Ltd
  • 2.3.1 Business Overview
  • 2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Crown Bioscience, Inc.
  • 2.4.1 Business Overview
  • 2.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 DiscoverX Corporation
  • 2.5.1 Business Overview
  • 2.5.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Explicyte
  • 2.6.1 Business Overview
  • 2.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Genscript Biotech Corporation
  • 2.7.1 Business Overview
  • 2.7.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 HD Biosciences Co.
  • 2.8.1 Business Overview
  • 2.8.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Horizon Discovery Group PLC
  • 2.9.1 Business Overview
  • 2.9.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 ImmunXperts SA
  • 2.10.1 Business Overview
  • 2.10.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Molecular Imaging, Inc.
  • 2.11.1 Business Overview
  • 2.11.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Promega Corporation,Personalis, Inc.
  • 2.12.1 Business Overview
  • 2.12.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 STC Biologics
  • 2.13.1 Business Overview
  • 2.13.2 Cancer Immunotherapy Drug Discovery Outsourcing Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competition, by Players

• 3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
  • 3.2.2 Top 10 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share
• 3.3 Market Competition Trend

4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions

• 4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Regions
• 4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 4.5 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

5 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries

• 5.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
• 5.2 USA Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

6 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries

• 6.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
• 6.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 6.3 UK Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 6.4 France Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries

• 7.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
• 7.2 China Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 7.5 India Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

8 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries

• 8.1 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
• 8.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Immunotherapy Drug Discovery Outsourcing by Countries

• 9.1 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2014-2019)

10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Type

• 10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Type (2019-2024)
• 10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
• 10.4 Immunomodulators Revenue Growth Rate (2014-2024)
• 10.5 Oncolytic Viral Therapies and Cancer Vaccines Revenue Growth Rate (2014-2024)
• 10.6 Other Revenue Growth Rate (2014-2024)

11 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Segment by Application

• 11.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2014-2019)
• 11.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Application (2019-2024)
• 11.3 Lung Revenue Growth (2014-2019)
• 11.4 Breast Revenue Growth (2014-2019)
• 11.5 Colorectal Revenue Growth (2014-2019)
• 11.6 Melanoma Revenue Growth (2014-2019)
• 11.7 Prostate Revenue Growth (2014-2019)
• 11.8 Head and Neck Revenue Growth (2014-2019)
• 11.9 Ovarian Revenue Growth (2014-2019)
• 11.10 Pancreatic Revenue Growth (2014-2019)

12 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)

• 12.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)
• 12.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Regions (2019-2024)
• 12.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
• 12.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
• 12.6 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology